Time-restricted feeding in overweight women

A clinical trial reveals the effects of time-restricted feeding in overweight women

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN11777276

Enrollment

Registered

2024-01-24

Start date

2021-02-01

Completion date

Unknown

Last updated

2024-02-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overweight women Nutritional, Metabolic, Endocrine

Interventions

8-hour time-restricted ad libitum eating for six weeks intervention While the beneficial impacts of time-restricted eating (TRE) on health extend beyond weight loss

it's crucial to recognize the potential influence of aligning eating patterns with the circadian rhythm. Nevertheless, the current body of TRE research remains limited, with clinical trials often a co

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Female 2. Aged between 19 and 65 years old 3. BMI: 25-29.99 kg/m2 4. Stable body weight for at least one month 5. Non-smoking 6. Consumption of < 140 g/wk of alcohol 7. Light exercise (<60 min/week of moderate exercise) 8. Consent, is indicated by signing the human-subject research agreement form

Exclusion criteria

Exclusion criteria: 1. Women on chronic medication use 2. Those with a pacemaker or platinum in their body 3. Individuals in the postmenopausal state 4. Pregnant or breastfeeding women 5. Individuals working shift work 6. Those with a history of cancer 7. Individuals with obsessive-compulsive disorder

Design outcomes

Primary

Measure	Time frame
The following primary outcome variables were assessed before the intervention and after the six-week follow-up period: 1. Body weight was measured using Tanita BC 545 N bioelectric impedance device-BIA 2. Body fat mass was measured using Tanita BC 545 N bioelectric impedance device-BIA 3. Waist circumference was measured using a non-stretching measuring tape ruler 4. Neck circumference was non-stretching measuring tape ruler 5. Blood glucose concentration was measured and calculated by biochemistry technicians in the biochemistry laboratory of Balikesir Atatürk City Hospital 6. Levels of insulin, HOMA-IR, LDL-C, HDL-C, triglyceride, and ALT were measured and calculated by biochemistry technicians in the biochemistry laboratory of Balikesir Atatürk City Hospital.	—

Measure

Time frame

The following primary outcome variables were assessed before the intervention and after the six-week follow-up period: 1. Body weight was measured using Tanita BC 545 N bioelectric impedance device-BIA 2. Body fat mass was measured using Tanita BC 545 N bioelectric impedance device-BIA 3. Waist circumference was measured using a non-stretching measuring tape ruler 4. Neck circumference was non-stretching measuring tape ruler 5. Blood glucose concentration was measured and calculated by biochemistry technicians in the biochemistry laboratory of Balikesir Atatürk City Hospital 6. Levels of insulin, HOMA-IR, LDL-C, HDL-C, triglyceride, and ALT were measured and calculated by biochemistry technicians in the biochemistry laboratory of Balikesir Atatürk City Hospital.

—

Secondary

Measure	Time frame
1. Dietary energy content was measured from the 24-hour dietary records of their food consumption using the BeBiS (Nutrition Information System) program (version 8.2). 2. Macronutrient levels were measured from the 24-hour dietary records of their food consumption using the BeBiS (Nutrition Information System) program (version 8.2).	—

Countries

Turkey

Contacts

Public ContactSaniye Bilici

sgbilici@gazi.edu.tr+903122162641

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026